The Rs 35 crore infusion, through the issue of additional equity shares is growth capital and is going to help us strengthen our position significantly. Upon conversion of warrants in due time, the company would be receiving an additional Rs 15 crore. The capital will be utilised primarily towards increasing the margin capital requirements for Networth
